| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c9faf891bdd318970bba39c126b05599
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4fd07571555396ab21f333e34fcbf12e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e7e0e42cba4bee6c48312821708b5d3a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2420-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-60 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-64 |
| filingDate |
2017-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4ca7cc30f1e03a10d2caeefd8ef6e35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c784a8f150d8b3ffcf12f0b192ccba95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6044db2537c2621f1442c5d8043b0c46 |
| publicationDate |
2019-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2019032105-A1 |
| titleOfInvention |
DEINTEGRIN VARIANTS AND USES THEREOF |
| abstract |
The present invention relates to disintegrin variants and methods for suppressing or inhibiting platelet aggregation in a subject in need thereof. The method comprises administering to the subject in need, an effective amount of said disintegrin variant to alleviate or alleviate symptoms associated with diseases, disorders and / or conditions resulting from platelet aggregation. According to preferred embodiments, the disintegrin variant according to the invention is applied in the form of a coating on an implantable device, such as a stent or catheter. |
| priorityDate |
2017-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |